Johnson & Johnson (JNJ)
146.82
-1.71
(-1.15%)
USD |
NYSE |
Apr 25, 16:00
146.50
-0.32
(-0.22%)
After-Hours: 20:00
Johnson & Johnson Market Cap: 353.85B for April 25, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 24, 2024 | 357.93B |
| April 23, 2024 | 360.41B |
| April 22, 2024 | 359.35B |
| April 19, 2024 | 356.43B |
| April 18, 2024 | 351.20B |
| April 17, 2024 | 348.86B |
| April 16, 2024 | 348.09B |
| April 15, 2024 | 355.66B |
| April 12, 2024 | 355.49B |
| April 11, 2024 | 358.55B |
| April 10, 2024 | 361.95B |
| April 09, 2024 | 366.99B |
| April 08, 2024 | 365.30B |
| April 05, 2024 | 367.23B |
| April 04, 2024 | 367.49B |
| April 03, 2024 | 371.73B |
| April 02, 2024 | 380.10B |
| April 01, 2024 | 380.22B |
| March 28, 2024 | 381.20B |
| March 27, 2024 | 380.65B |
| March 26, 2024 | 375.37B |
| March 25, 2024 | 374.05B |
| March 22, 2024 | 374.07B |
| March 21, 2024 | 375.32B |
| March 20, 2024 | 375.35B |
| Date | Value |
|---|---|
| March 19, 2024 | 376.43B |
| March 18, 2024 | 377.76B |
| March 15, 2024 | 381.18B |
| March 14, 2024 | 383.66B |
| March 13, 2024 | 388.22B |
| March 12, 2024 | 392.17B |
| March 11, 2024 | 388.53B |
| March 08, 2024 | 384.41B |
| March 07, 2024 | 382.84B |
| March 06, 2024 | 383.97B |
| March 05, 2024 | 385.49B |
| March 04, 2024 | 385.18B |
| March 01, 2024 | 390.67B |
| February 29, 2024 | 388.89B |
| February 28, 2024 | 389.30B |
| February 27, 2024 | 387.93B |
| February 26, 2024 | 387.31B |
| February 23, 2024 | 389.83B |
| February 22, 2024 | 386.49B |
| February 21, 2024 | 382.22B |
| February 20, 2024 | 380.25B |
| February 16, 2024 | 377.09B |
| February 15, 2024 | 380.39B |
| February 14, 2024 | 375.14B |
| February 13, 2024 | 376.90B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
293.00B
Minimum
Mar 23 2020
489.47B
Maximum
Apr 25 2022
408.41B
Average
408.27B
Median
Apr 24 2020
Market Cap Benchmarks
| Amgen Inc | 144.37B |
| Gilead Sciences Inc | 81.33B |
| Eli Lilly and Co | 689.30B |
| Merck & Co Inc | 331.78B |
| Shockwave Medical Inc | 12.31B |
Market Cap Related Metrics
| PE Ratio | 10.24 |
| PS Ratio | 4.110 |
| PEG Ratio | 0.0512 |
| Price to Book Value | 5.145 |
| Price | 146.82 |
| Earnings Yield | 9.77% |
| PEGY Ratio | 0.0504 |
| Operating PE Ratio | 15.95 |
| Normalized PE Ratio | 17.94 |